TABLE 4.
Distribution of TCGA classification*.
| EC | DC | CS | SC | LCNEC | |
|---|---|---|---|---|---|
| POLEmut | 3 | 0 | 0 | 0 | 0 |
| MMR-d | 6 | 3 | 1 | 1 | 0 |
| p53mut | 2 | 0 | 2 | 8 | 1 |
| NSMP | 8 | 0 | 1 | 0 | 0 |
| 36 | 19 | 3 | 4 | 9 | 1 |
*Case no. 27, which exhibits both p53mut and MMR-d features, is categorized as p53mut type. EC, endometrioid carcinoma; DC, dedifferentiated edometrioid carcinoma; CS, carcinosarcoma; SC, seous carcinoma; LCNEC, neuroendocrine carcinoma; PLOEmut, POLE, mutation; MMR-d, mismatch repair-deficient; NSMP, no specific molecular profile; p53mut, p53 mutation.